MedX Health Corp (CVE:MDX – Get Free Report)’s share price traded down 20% on Wednesday . The company traded as low as C$0.04 and last traded at C$0.04. 340,400 shares traded hands during trading, an increase of 305% from the average session volume of 83,978 shares. The stock had previously closed at C$0.05.
MedX Health Stock Performance
The stock has a fifty day moving average price of C$0.06 and a 200-day moving average price of C$0.06. The firm has a market capitalization of C$16.40 million, a PE ratio of -5.00 and a beta of 0.47.
About MedX Health
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
Further Reading
- Five stocks we like better than MedX Health
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
